Smart Immune
Biotechnology ResearchView the employees at
Smart Immune-
Laura Simons Associate Director Medical Development at Smart Immune, hematopoietic stem cell-based biotherapies
-
Heidelberg, Baden-Württemberg, Germany
-
Rising Star
Jérémy MANCEAU Technicien qualifié développement Bioprocédé à Smartimmune-
Viry-Châtillon, Île-de-France, France
-
Rising Star
Ranjita Devi Moirangthem (Ph.D) Researcher: Cellular Immunotherapy (T-cell progenitor, NK)-
Paris, Île-de-France, France
-
Rising Star
Espérance KOKA Apprentie Technicienne supérieure en Thérapie cellulaire Chez Smart Immune-
Greater Paris Metropolitan Region
-
Rising Star
Overview
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T-cell progenitor therapy platform to fully and rapidly re-arm the immune system, enabling next-generation allogeneic T-cell therapies. The company is a spin-off from the Imagine Institute of Genetic Diseases, and was founded in 2017 by Karine Rossignol, PharmD-HEC, Marina Cavazzana, MD-PhD and Isabelle André, PhD to transform outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has clinical partnerships with leading institutions in the US and Europe. The ProTcell platform, already in Phase I/II clinical trials, enables the accelerated recovery of a complete immune repertoire in patients fighting cancer and infection. The ProTcell platform introduces potent, allogeneic T-cell progenitors which are then differentiated by the thymus into fully functional T-cells, to ultimately develop an ‘off the shelf’ T-cell medicine. The company is headquartered in Paris, France, at Paris Biotech Santé.
-